(Q50592573)

16 March 2018

title

Long-term treatment of type III hyperlipoproteinemia with clofibrate (English)

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

9 May 2024

author name string

P. M. Stuyt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7332612

9 May 2024

P. N. Demacker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7332612

9 May 2024

A. Van't Laar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7332612

9 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7332612

9 May 2024

publication date

1 November 1981

1 reference

16 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:002191508190143X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

https://api.elsevier.com/content/article/PII:002191508190143X?httpAccept=text/plain

9 May 2024

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

9 May 2024

1 reference

16 March 2018

volume

40

1 reference

16 March 2018

issue

3-4

1 reference

16 March 2018

page(s)

329-336

1 reference

16 March 2018

Abnormal lipid composition of chylomicrons in broad-β disease (type III hyperlipoproteinemia)

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Broad-β disease versus endogenous hypertriglyceridemia: Levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia

9 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia

9 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Treatment of hyperlipidemias

9 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

9 May 2024

Discussants

7

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia

9 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy

9 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Type III Hyperlipoproteinemia: An Analysis of Two Contemporary Definitions

9 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia)

9 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

A new method for the direct determination of serum cholesterol

9 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

[A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method]

9 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

An improved semi-automated method for the colorimetric determination of triglycerides in serum

9 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Separation and quantitative analysis of serum lipoproteins by means of electrophoresis on cellulose acetate

9 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

A Lipoprotein Staining Method for Zone Electrophoresis

9 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Letter: Reduction of serum-alkaline-phosphatase by clofibrate

9 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Effects of hyperlipoproteinemias and their treatment on the peripheral circulation

9 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

Gallbladder Disease as a Side Effect of Drugs Influencing Lipid Metabolism Experience in the Coronary Drug Project

9 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

9 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0021-9150(81)90143-X

9 May 2024

Identifiers

1 reference

16 March 2018

1 reference

16 March 2018